In clinical studies on patients (including pediatric patients) with acute kidney injury (AKI), DAMPs, specifically S100A8/S100A9 and urine mitochondrial DNA (mtDNA), have been identified as potential diagnostic and prognostic biomarkers, reflecting, for example, the severity of this disease (115–117). Here, S100A8 is linked to acute kidney injury.